# Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients

> **NCT02478580** · PHASE3 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 67 (actual)

## Conditions studied

- Obesity
- Premature Recovery From Anesthesia

## Interventions

- **DRUG:** Nuvigil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02478580
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-09
- **Final completion:** 2016-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478580, "Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02478580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*